Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity

Xingjuan Shi1, Yujue Wang2, Xiaoou Sun3

  • 1Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University, Nanjing 210096, China. xingjuanshi@seu.edu.cn.

Insights

Centrosomal protein 70 (Cep70) regulates breast cancer growth and metastasis. This study shows Cep70 mediates paclitaxel sensitivity by interacting with tubulin and promoting microtubule assembly in breast cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Centrosome aberrations are linked to breast cancer development and progression.
  • Centrosomal protein 70 (Cep70) was previously shown to regulate breast cancer growth and metastasis.

Purpose of the Study:

  • To investigate the role of Cep70 in paclitaxel sensitivity in breast cancer.
  • To determine if Cep70 influences the efficacy of anti-microtubule chemotherapy.

Main Methods:

  • Cell proliferation assays were used to assess paclitaxel sensitivity.
  • Cep70 expression levels were altered to observe effects on drug sensitivity.
  • Mechanistic studies involving tubulin interaction and microtubule assembly assays were performed.

Main Results:

  • Cep70 expression levels positively correlated with paclitaxel sensitivity in breast cancer cell lines.
  • Altering Cep70 expression significantly modulated paclitaxel sensitivity.
  • Cep70 was found to interact with tubulin, enhancing paclitaxel-induced microtubule assembly.

Conclusions:

  • Cep70 acts as a mediator of paclitaxel sensitivity in breast cancer.
  • Cep70's interaction with tubulin and promotion of microtubule assembly are key mechanisms underlying its role in drug response.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.1K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
6.1K